Search BRITE hierarchies
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AG Alpha and beta blocking agents
C07AG02 Carvedilol [DG:DG00321]
D03415 Carvedilol phosphate (USAN) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Beta-adrenergic Blocking Agents
Beta-adrenergic Blocking Agents, Other
Carvedilol [DG:DG00321]
D03415 Carvedilol phosphate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG03180 alpha1 and beta-Adrenergic receptor antagonist
DG00321 Carvedilol
D03415 Carvedilol phosphate
DG03231 Antihypertensive
DG03180 alpha1 and beta-Adrenergic receptor antagonist
DG00321 Carvedilol
D03415 Carvedilol phosphate
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00321 Carvedilol
D03415 Carvedilol phosphate
DG01642 CYP2C9 substrate
DG00321 Carvedilol
D03415 Carvedilol phosphate
DG01644 CYP2D6 substrate
DG00321 Carvedilol
D03415 Carvedilol phosphate
DG02855 CYP2E1 substrate
DG00321 Carvedilol
D03415 Carvedilol phosphate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00321 Carvedilol
D03415 Carvedilol phosphate
Transporter inhibitor
DG01622 ABCB1 inhibitor
DG00321 Carvedilol
D03415 Carvedilol phosphate
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D03415 Carvedilol phosphate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
D03415 Carvedilol phosphate (USAN) <US>
ADRB1 [HSA:153] [KO:K04141]
D03415 Carvedilol phosphate (USAN) <US>
ADRB2 [HSA:154] [KO:K04142]
D03415 Carvedilol phosphate (USAN) <US>
Drug metabolizing enzymes and transporters [br08309.html]
D03415
Pharmacogenomic biomarkers [br08341.html]
D03415
[ BRITE | KEGG2 | KEGG ]